Maxime is CFO of AmorChem and one of its Partners. He is responsible for the accounting, financial management and fiscal strategy of the fund. He also created a structure which enables AmorChem to leverage the research-focused financial tools available to the life sciences industry. His crafting of a comprehensive model to predict the risk-adjusted return of projects has been very helpful in setting the fund’s investment strategy. In addition, he set up and maintained the accounting systems as well as developed the financial strategy for NuChem Therapeutics, a medicinal chemistry service provider. He is very active in the local investment industry and established the Nouvelle Génération committee of Réseau-Capital.
After gaining experience at Caisse de dépôt et de placement du Québec and in a small private company, Maxime joined the AgeChem Venture Fund in 2006 as director of finance. He obtained a BComm in accounting from HEC Montréal. He was awarded the designation of CPA, CMA and holds the title of Chartered Financial Analyst (CFA).